Correlation Between CanSino Biologics and AECOM TECHNOLOGY

Can any of the company-specific risk be diversified away by investing in both CanSino Biologics and AECOM TECHNOLOGY at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CanSino Biologics and AECOM TECHNOLOGY into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CanSino Biologics and AECOM TECHNOLOGY, you can compare the effects of market volatilities on CanSino Biologics and AECOM TECHNOLOGY and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CanSino Biologics with a short position of AECOM TECHNOLOGY. Check out your portfolio center. Please also check ongoing floating volatility patterns of CanSino Biologics and AECOM TECHNOLOGY.

Diversification Opportunities for CanSino Biologics and AECOM TECHNOLOGY

0.52

Correlation Coefficient

CanSino Biologics  AECOM TECHNOLOGY

Very weak diversification

The 3 months correlation between CanSino and AECOM is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding CanSino Biologics and AECOM TECHNOLOGY in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AECOM TECHNOLOGY and CanSino Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CanSino Biologics are associated (or correlated) with AECOM TECHNOLOGY. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AECOM TECHNOLOGY has no effect on the direction of CanSino Biologics i.e., CanSino Biologics and AECOM TECHNOLOGY go up and down completely randomly.

Pair Corralation between CanSino Biologics and AECOM TECHNOLOGY

Assuming the 90 days trading horizon CanSino Biologics is expected to under-perform the AECOM TECHNOLOGY. In addition to that, CanSino Biologics is 3.39 times more volatile than AECOM TECHNOLOGY. It trades about -0.08 of its total potential returns per unit of risk. AECOM TECHNOLOGY is currently generating about 0.07 per unit of volatility. If you would invest  10,274  in AECOM TECHNOLOGY on October 24, 2024 and sell it today you would earn a total of  126.00  from holding AECOM TECHNOLOGY or generate 1.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

CanSino Biologics  vs.  AECOM TECHNOLOGY

CanSino Biologics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CanSino Biologics unveiled solid returns over the last few months and may actually be approaching a breakup point.

AECOM TECHNOLOGY

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in AECOM TECHNOLOGY are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, AECOM TECHNOLOGY may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with CanSino Biologics and AECOM TECHNOLOGY

The main advantage of trading using opposite CanSino Biologics and AECOM TECHNOLOGY positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CanSino Biologics position performs unexpectedly, AECOM TECHNOLOGY can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AECOM TECHNOLOGY will offset losses from the drop in AECOM TECHNOLOGY's long position.

The idea behind CanSino Biologics and AECOM TECHNOLOGY pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.